Loading
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Apr 2022 for Better Therapeutics, Inc., €4,445. Read the official filing
Filing timeline
BuySaleKevin J. Appelbaum
Insider track record
Disclosed buys
5
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-40.9%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Kevin J. Appelbaum: trading record in brief
Kevin J. Appelbaum (chief executive) discloses dealings in Better Therapeutics, Inc. to SEC (Form 4). Between 2 December 2021 and 31 March 2022, the trades on record add up to 5 filings.
The open-market record is one-sided, with 5 purchases worth €20k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2022 to date brings 1 purchase and no sales.
In size, the median ticket on the buying side is €4,091. Of 5 purchases, 2 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The latest filing, published on 4 April 2022, reports an open-market purchase of €4,445 in Better Therapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kevin J. Appelbaum
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
2,500 shares@ US$1.968530.3% of flowCommon StockSEC:0000899243-22-013342:0
Canonical exit: 29 Jun 2022 (T+90)
1,000 shares@ US$4.599927.8% of flowCommon StockSEC:0000899243-21-049425:0
Canonical exit: 20 Mar 2022 (T+90)
750 shares@ US$4.706521.3% of flowCommon StockSEC:0000899243-21-048904:0
Canonical exit: 15 Mar 2022 (T+90)
1,000 shares@ US$5.975226.5% of flowCommon StockSEC:0000899243-21-048151:0
Canonical exit: 10 Mar 2022 (T+90)
500 shares@ US$6.8420.6% of flowCommon StockSEC:0000899243-21-046974:0
Canonical exit: 2 Mar 2022 (T+90)
5 of 5 declarations
